Mounjaro Drug Tirzepatide Could Treat Sleep Apnea, Study Finds

  • 📰 ForbesTech
  • ⏱ Reading Time:
  • 16 sec. here
  • 7 min. at publisher
  • 📊 Quality Score:
  • News: 27%
  • Publisher: 59%

Mounjaro News

Zepbound,Ozempic,Sleep Apnea

Robert Hart is a senior reporter for Forbes covering science, technology and health with a frequent focus on artificial intelligence, space, weight loss drugs and emerging technologies. He joined Forbes in 2020 and is based in London. Rob has covered everything from the billionaire space race, the health impacts of overturning Roe v.

Who Is Timothy Mellon? Trump’s Biggest Donor Is A Secretive Billionaire Banking Scion Who Paid $53 Million For Border Wall.

Tirzepatide significantly reduced the number of breathing interruptions during sleep — a key measure of disease severity — for clinically obese people living with moderate-to-severe obstructive sleep apnea, according to the results of two clinical trials published in the New England Journal of Medicine.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 318. in TECHNOLOGY

Technology Technology Latest News, Technology Technology Headlines